PHARMA MAR, S.A. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.68 EUR | -1.55% |
|
-6.47% | -35.20% |
| Feb. 29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 | |
| Feb. 28 | Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Pharma Mar, S.A.
Price target over the last 5 years
History of analyst recommendation changes
cb1e2f4458.6R785rPIr5TigxtRWCOp9wJr3HIHOooBy5LwC53pJl8.rnXNsPaa56aE23U3P2n_vnoIrjhVF-01qvHBb-qreRiGJ6yE-6ThxbbmQg~2fbf4967677bf44c8e2933964c8e2a76
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
27.1
EUR
Average target price
49.4
EUR
Spread / Average Target
+82.29%
High Price Target
70
EUR
Spread / Highest target
+158.30%
Low Price Target
30
EUR
Spread / Lowest Target
+10.70%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- PHM Stock
- Consensus Pharma Mar, S.A.
